---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-045152"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:16:03.563402+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SBC Medical Q3 revenue $53M (+12% YoY); net income falls to $2M from $8M

## Summary
- Q3 revenue $53M (+12% YoY); operating income $13M (-31% YoY, hit by $12.8M stock-based comp).
- Q3 net income attributable to SBC was $2M vs $8M in Q3 2023; nine-month net income $40M (+60%).
- Nine-month revenue $160M (+23%), EBITDA $68M (+21%), EBITDA margin 42%.
- Partner clinics reached 224 as of Sep 30, 2024, up 24 from a year ago.
- Stock-based compensation of $12.8M in Q3 related to listing process reduced operating income.

## SEC filing metadata
- accession: 0001493152-24-045152
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/0001493152-24-045152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000149315224045152/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-045152
- JSON: https://secwatch.observer/filing/0001493152-24-045152.json
- Plain text: https://secwatch.observer/filing/0001493152-24-045152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.